In contrast to WHO 2021, which makes recommendations without taking CD4 + levels into account (tuberculosis at non-neurological site, start ART within 2 weeks; tuberculosis meningitis, start at 4–8 weeks), Malawi, Nigeria, and Uganda require a CD4 + count to define when to start ART. The gene discussed is CD4; the disease is tuberculosis.